SARS-CoV-2

Agnes Hajduczki1,2, William C Chang1,2, Rafael De La Barrera3

  • 1Viral Diseases Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.

Vaccines
|October 28, 2025
PubMed
概括

一种针对SARS-CoV-2的新型Spike Ferritin Nanoparticle (SpFN) 候选疫苗在CGMP条件下迅速开发和制造. 该SpFN疫苗表现出稳定性,并引起了针对多种COVID-19变异的强有力的中和抗体.